Carla Masini

588 total citations
34 papers, 376 citations indexed

About

Carla Masini is a scholar working on Occupational Therapy, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carla Masini has authored 34 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Occupational Therapy, 9 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carla Masini's work include Safe Handling of Antineoplastic Drugs (9 papers), Pharmaceutical studies and practices (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Carla Masini is often cited by papers focused on Safe Handling of Antineoplastic Drugs (9 papers), Pharmaceutical studies and practices (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Carla Masini collaborates with scholars based in Italy, Tanzania and Germany. Carla Masini's co-authors include Ugo De Giorgi, Lorena Rossi, Elisa Carretta, Vincenza Conteduca, Cecilia Menna, Salvatore Luca Burgio, Mattia Altini, Samanta Salvi, Daniele Calistri and Valentina Casadio and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Carla Masini

28 papers receiving 369 citations

Peers

Carla Masini
Cristina Teragni Italy
Sherry A. Goodner United States
James D Mellor Australia
Dominic A. Solimando United States
Scott A. Soefje United States
Mary D. Chamberlin United States
Sam C. Augustine United States
V J O'Neill United Kingdom
Elisa De Carlo Italy
Karine Bouhier‐Leporrier France
Cristina Teragni Italy
Carla Masini
Citations per year, relative to Carla Masini Carla Masini (= 1×) peers Cristina Teragni

Countries citing papers authored by Carla Masini

Since Specialization
Citations

This map shows the geographic impact of Carla Masini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Masini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Masini more than expected).

Fields of papers citing papers by Carla Masini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Masini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Masini. The network helps show where Carla Masini may publish in the future.

Co-authorship network of co-authors of Carla Masini

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Masini. A scholar is included among the top collaborators of Carla Masini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Masini. Carla Masini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iorio, Valentina Di, Stefano Boschi, Maddalena Sansovini, et al.. (2025). How Regulation 536/2014 Is Changing Academic Research with Therapeutic Radiopharmaceuticals: A Local Experience. Pharmaceuticals. 18(11). 1709–1709.
2.
Botticelli, Andrea, Ovidio Brignoli, Francesco Caruso, et al.. (2025). Breast Immunology Network: Toward a Multidisciplinary and Integrated Model for Breast Cancer Care in Italy. Cancers. 17(18). 3089–3089.
3.
Boschi, Stefano, Manuela Monti, Paola Caroli, et al.. (2025). Production and Quality Control of [68Ga]Ga-FAPI-46: Development of an Investigational Medicinal Product Dossier for a Bicentric Clinical Trial. Pharmaceuticals. 18(10). 1475–1475.
4.
Giunta, Emilio Francesco, et al.. (2024). New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact. Expert Opinion on Drug Metabolism & Toxicology. 20(6). 491–502. 4 indexed citations
5.
Altini, Mattia, Roberta Maltoni, Ilaria Massa, et al.. (2024). Body weight and body surface area of adult patients with selected cancers: An Italian multicenter study. PLoS ONE. 19(12). e0314452–e0314452.
6.
7.
Iorio, Valentina Di, Stefano Boschi, Anna Sarnelli, et al.. (2021). [18F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality Issue. Pharmaceuticals. 14(7). 599–599. 3 indexed citations
8.
Bravaccini, Sara, Patrizia Serra, Dino Amadori, et al.. (2021). Setting Up a Medical Oncology Educational Program in Sub-Saharan Africa. Annals of Global Health. 87(1). 81–81.
9.
Altini, Mattia, Gerardo Musuraca, Roberta Maltoni, et al.. (2020). The challenge of sustainability in healthcare systems: economic and organizational impact of subcutaneous formulations for rituximab and trastuzumab in onco-hematology. Expert Review of Pharmacoeconomics & Outcomes Research. 21(3). 503–509. 11 indexed citations
10.
Bongiovanni, Alberto, et al.. (2020). Pembrolizumab in a Patient With Heavily Pre-Treated Squamous Cell Thymic Carcinoma and Cardiac Impairment: A Case Report and Literature Review. Frontiers in Oncology. 10. 1478–1478. 6 indexed citations
11.
Monti, Manuela, Bernadette Vertogen, Carla Masini, et al.. (2020). Hydroxychloroquine as Prophylaxis for COVID-19: A Review. Frontiers in Pharmacology. 11. 605185–605185. 7 indexed citations
12.
Cangini, Delia, Carla Masini, Andrea Ghelli Luserna di Rorà, et al.. (2020). Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hope. Minerva Medica. 111(5). 467–477. 9 indexed citations
13.
Serra, Patrizia, Nestory Masalu, Dino Amadori, et al.. (2019). Evaluating the appropriateness of chemotherapy in a low‐resource cancer centre in sub‐Saharan Africa. Cancer Medicine. 9(1). 133–140. 6 indexed citations
14.
15.
Casadei‐Gardini, Andrea, Elena Tenti, Carla Masini, et al.. (2016). Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions. Oncotarget. 7(26). 40719–40724. 6 indexed citations
16.
Salvi, Samanta, Valentina Casadio, Vincenza Conteduca, et al.. (2015). Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone. British Journal of Cancer. 112(10). 1717–1724. 98 indexed citations
17.
Masini, Carla, et al.. (2014). Automated preparation of chemotherapy: Quality improvement and economic sustainability. American Journal of Health-System Pharmacy. 71(7). 579–585. 47 indexed citations
18.
Conteduca, Vincenza, Salvatore Luca Burgio, Cecilia Menna, et al.. (2014). Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide. The Prostate. 74(16). 1691–1696. 49 indexed citations
19.
20.
Giani, Paolo, Roberto Latini, Aldo P. Maggioni, et al.. (1990). A multicenter, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Preliminary report. 6. 307–311. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Teragni Breakdown of academic impact, for papers by Sherry A. Goodner Breakdown of academic impact, for papers by James D Mellor Breakdown of academic impact, for papers by Dominic A. Solimando Breakdown of academic impact, for papers by Scott A. Soefje Breakdown of academic impact, for papers by Mary D. Chamberlin Breakdown of academic impact, for papers by Sam C. Augustine Breakdown of academic impact, for papers by V J O'Neill Breakdown of academic impact, for papers by Elisa De Carlo Breakdown of academic impact, for papers by Karine Bouhier‐Leporrier
Rankless by CCL
2026